FFR-CT的使用与效能:真实世界多中心临床数据审计及成本分析
该多中心审计覆盖英格兰FFR-CT集中资助的3年,纳入12个中心2298例CCTA转诊FFR-CT分析,评估其与NICE指南的符合度、以有创FFR为参考的诊断准确性及成本。稳定胸痛占77%、临界狭窄(50%-69%)占40%,FFR-CT阳性与阴性预测值分别为49%和76%;平均随访17个月发生46例事件(2%),FFR-CT(阈值0.80)无预测价值;FFR-CT策略每例花费£2,102,应激影像平均£1,411。
要点
- FFR-CT阳性预测值仅49%,阴性预测值76%,阳性结果需谨慎解读。
- 仅40%的CCTA存在临界狭窄(50%-69%),与NICE使用标准存在差距。
- FFR-CT(阈值0.80)在平均17个月随访中未预测不良事件。
核心结论
- 真实世界中NICE关于FFR-CT的使用标准在症状方面约四分之三符合、在狭窄方面仅40%符合;FFR-CT阳性预测值低,使其策略可能比传统应激影像更昂贵。
研究设计与样本
- 多中心审计,覆盖英格兰FFR-CT集中资助的3年,12个中心共2298例CCTA接受FFR-CT分析;以有创FFR为参考标准评估诊断准确性,并随访非致死性心肌梗死和全因死亡;采用成本分析模型比较FFR-CT策略与替代应激影像路径。
诊断标准与关键数值
- FFR-CT阳性预测值为49%,阴性预测值为76%;FFR-CT阈值0.80在平均17个月随访中对非致死性心肌梗死和全因死亡无预测价值。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Fractional flow reserve-computed tomography (FFR-CT) is endorsed by UK and U.S. chest pain guidelines, but its clinical effectiveness and cost benefit in real-world practice are unknown.
OBJECTIVES: The purpose of this study was to audit the use of FFR-CT in clinical practice against England's National Institute for Health and Care Excellence guidance and assess its diagnostic accuracy and cost.
METHODS: A multicenter audit was undertaken covering the 3 years when FFR-CT was centrally funded in England. For coronary computed tomographic angiograms (CCTAs) submitted for FFR-CT analysis, centers provided data on symptoms, CCTA and FFR-CT findings, and subsequent management. Audit standards included using FFR-CT only in patients with stable chest pain and equivocal stenosis (50%-69%). Diagnostic accuracy was evaluated against invasive FFR, when performed. Follow-up for nonfatal myocardial infarction and all-cause mortality was undertaken. The cost of an FFR-CT strategy was compared to alternative stress imaging pathways using cost analysis modeling.
RESULTS: A total of 2,298 CCTAs from 12 centers underwent FFR-CT analysis. Stable chest pain was the main symptom in 77%, and 40% had equivocal stenosis. Positive and negative predictive values of FFR-CT were 49% and 76%, respectively. A total of 46 events (2%) occurred over a mean follow-up period of 17 months; FFR-CT (cutoff: 0.80) was not predictive. The FFR-CT strategy costs £2,102 per patient compared with an average of £1,411 for stress imaging.
CONCLUSIONS: In clinical practice, the National Institute for Health and Care Excellence criteria for using FFR-CT were met in three-fourths of patients for symptoms and 40% for stenosis. FFR-CT had a low positive predictive value, making its use potentially more expensive than conventional stress imaging strategies.
引用
- Mittal TK, Hothi SS, Venugopal V, et al. The Use and Efficacy of FFR-CT: Real-World Multicenter Audit of Clinical Data With Cost Analysis. JACC Cardiovasc Imaging. 2023. PMID: 37052559. doi:10.1016/j.jcmg.2023.02.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。